SpringWorks Therapeutics, Inc. (SWTX)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,481	2,687	2,682	1,616	3,020	3,476
Market Cap Growth	-8.83%	0.18%	65.95%	-46.48%	-13.11%	109.99%
Enterprise Value	3,106	2,196	2,267	970	2,541	3,199
Last Close Price	46.22	36.13	36.50	26.01	61.98	72.52
PS Ratio	15.66	14.02	492.39	-	-	99.31
PB Ratio	8.30	5.59	4.28	2.90	7.15	6.24
P/TBV Ratio	8.34	5.77	4.36	2.90	7.15	6.24
EV/Sales Ratio	14.14	11.46	416.18	-	-	91.40
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.00	0.01
Asset Turnover	0.38	0.29	0.01	-	-	0.08
Inventory Turnover	1.69	1.89	-	-	-	-
Quick Ratio	3.99	3.54	6.21	11.60	12.46	28.88
Current Ratio	4.33	3.81	6.41	11.75	12.78	29.15
Return on Equity (ROE)	-51.57%	-46.62%	-54.90%	-56.58%	-35.51%	-10.37%
Return on Assets (ROA)	-28.47%	-26.48%	-31.62%	-32.40%	-21.08%	-6.36%
Return on Capital (ROIC)	-33.13%	-30.98%	-35.83%	-35.54%	-22.05%	-6.57%
Earnings Yield	-7.29%	-9.61%	-12.12%	-17.16%	-5.76%	-1.31%
FCF Yield	-4.86%	-6.70%	-8.58%	-10.63%	-4.30%	-0.95%
Buyback Yield / Dilution	-12.77%	-17.44%	-18.45%	-9.88%	-12.00%	-226.18%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q